{"messages":[{"status":"ok","cursor":"4110","count":30,"total":8966}], "collection":[{"rel_doi":"10.1101\/2020.06.06.20124313","rel_title":"Closed form solution of the SIR model for the COVID-19 outbreak in Italy","rel_date":"2020-06-08","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.06.20124313","rel_abs":"The CODIV-19 outbreak in early 2020 generated a tremendous effort of epidemiologists and researchers to fit the experimental data with the solutions of the SIR model equations or with more sophisticated models. In this paper we show that under same hypotheses, a closed form solution exists that reasonably fits the experimental data for Italy, and the results can be extended to any other area.","rel_num_authors":1,"rel_authors":[{"author_name":"Riccardo Giubilei","author_inst":"Private"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.06.05.20123646","rel_title":"A scaling approach to estimate the COVID-19 infection fatality ratio from incomplete data","rel_date":"2020-06-08","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123646","rel_abs":"SARS-CoV-2 has disrupted the life of billions of people around the world since the first outbreak was officially declared in China at the beginning of 2020. Yet, important questions such as how deadly it is or its degree of spread within different countries remain unanswered. In this work, we exploit the 'universal' growth of the mortality rate with age observed in different countries since the beginning of their respective outbreaks, combined with the results of the antibody prevalence tests in the population of Spain, to unveil both unknowns. We validate these results with an analogous antibody rate survey in the canton of Geneva, Switzerland. We also argue that the official number of deaths over 70 years old is importantly underestimated in most of the countries, and we use the comparison between the official records with the number of deaths mentioning COVID-19 in the death certificates to quantify by how much. Using this information, we estimate the fatality infection ratio (IFR) for the different age segments and the fraction of the population infected in different countries assuming a uniform exposure to the virus in all age segments. We also give estimations for the non-uniform IFR using the sero-epidemiological results of Spain, showing a very similar growth of the fatality ratio with age. Only for Spain, we estimate the probability (if infected) of being identified as a case, being hospitalized or admitted in the intensive care units as function of age. In general, we observe a nearly exponential growth of the fatality ratio with age, which anticipates large differences in total IFR in countries with different demographic distributions, with numbers that range from 1.82% in Italy, to 0.62% in China or even 0.14% in middle Africa.","rel_num_authors":1,"rel_authors":[{"author_name":"Beatriz Seoane","author_inst":"Sorbonne University"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.06.06.20124198","rel_title":"Predictors of Mental Health during the early Covid-19 Pandemic in the US: role of economic concerns, health worries and social distancing","rel_date":"2020-06-08","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.06.20124198","rel_abs":"Objective: To assess mental health in the US adult population in the Covid-19 pandemic and explore the roles of economic concerns, health worries and social distancing in shaping mental health outcomes. Methods: We analyze online survey data from the \"Understanding America Study\" (UAS) that is representative of the US adult population and covers the period of March 10-31st 2020 (sample size: 6436). Results: About 29% (CI:27.4-.30.4%) of the US adult population reported some depression\/anxiety symptoms over the study period, with symptoms deteriorating over the month of March. Worsening mental health was most strongly associated with concerns about the economic consequences of the pandemic, while concerns about the potential impact of the virus on respondents' own health and the practice of social distancing also predicted the presence of depression and anxiety symptoms, albeit less strongly. Conclusions: Our findings point towards a major mental health crisis unfolding simultaneously with the pandemic in the US. They also highlight the importance of economic countermeasures and social policy for mitigating the impact of Covid-19 on adult mental health in the US over and above an effective public health response.","rel_num_authors":6,"rel_authors":[{"author_name":"Fabrice Kampfen","author_inst":"University of Pennsylvania"},{"author_name":"Iliana V. Kohler","author_inst":"University of Pennsylvania"},{"author_name":"Alberto Ciancio","author_inst":"University of Pennsylvania"},{"author_name":"Wandi Bruine de Bruin","author_inst":"University of Southern California"},{"author_name":"Juergen Maurer","author_inst":"University of Lausanne"},{"author_name":"Hans-Peter Kohler","author_inst":"University of Pennsylvania"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.06.07.20124602","rel_title":"Laboratory findings in coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis","rel_date":"2020-06-08","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.07.20124602","rel_abs":"Background: In early December 2019, the first patient with COVID-19 pneumonia was found in Wuhan, Hubei Province, China. Recent studies have suggested the role of primary laboratory tests in addition to clinical symptoms for suspected patients, which play a significant role in the diagnosis of COVID-19. Therefore, the present study was conducted to evaluate laboratory findings in COVID-19 patients. Material and methods: The present meta-analysis was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. This protocol is registered with the code CRD42019145410 in PROSPERO International Database. Results: Finally, 52 studies involving 5490 patients with COVID-19 entered the meta-analysis process. The prevalence of leukopenia, lymphopenia, elevated c-reactive protein (CRP), elevated erythrocyte sedimentation rate (ESR), elevated serum amyloid A, elevated ferritin was estimated to be 20.9% (95%CI: 17.9-24.3), 51.6% (95%CI: 44.0-59.1), 63.6% (95%CI: 57.0-69.8), 62.5% (95%CI: 50.1-73.5), 63.6% (95%CI: 57.0-69.8), 62.5% (95%CI: 50.1-73.5), 74.7% (95%CI: 50.0-89.7), and 72.6% (95%CI: 58.1-83.5), respectively. The prevalence of elevated interleukin-6 was 59.9% (95%CI: 48.2-70.5), CD3 was 68.3% (95%CI: 50.1-82.2), reduced CD4 was 62.0% (95%CI: 51.1-71.6), reduced CD8 was 42.7% (95%CI: 32.2-53.9). The prevalence of elevated troponin-I was 20.6% (95%CI: 9.0-40.5), elevated creatine kinase-MB (CKMB) was 14.7% (95%CI: 7.1-28.0), elevated brain natriuretic peptide (BNP) was 48.9% (95%CI: 30.4-67.7), elevated blood urea nitrogen was 13.1% (95%CI: 6.6-24.4),, elevated creatinine was 7.2% (95%CI: 4.4-11.8), elevated lactate dehydrogenase (LDH) was 53.1% (95%CI: 43.6-62.4), hyperglycemia was 41.1% (95% CI: 28.2-55.5), elevated total bilirubin was 48.9% (95%CI: 30.4-67.7), reduced albumin was 54.7% (95%CI: 38.1-70.2), reduced pre-albumin was 49.0% (95%CI: 26.6-71.8), and reduced PT was 53.1% (95% CI: 43.6-62.4), and D-dimer was 44.9% (95%CI: 31.0-59.6). Conclusion This study provides a comprehensive description of laboratory characteristics in patients with COVID-19. The results show that lymphopenia, elevated CRP, elevated ESR, elevated ferritin, elevated serum amyloid A, elevated BNP, reduced albumin, reduced pre-albumin, reduced CD3, reduced CD4, reduced CD8, elevated D-dimer, reduced PT, elevated interleukin-2, elevated interleukin-6, elevated LDH and hyperglycemia are the common findings at the time of admission.","rel_num_authors":4,"rel_authors":[{"author_name":"Mohammad Karimian","author_inst":"Assistant Professor, Department of General Surgery, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran"},{"author_name":"Amirreza Jamshidbeigi","author_inst":"Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran"},{"author_name":"Gholamreza Badfar","author_inst":"Assistant Professor, Department of Pediatric, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran"},{"author_name":"Milad Azami","author_inst":"Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran"},{"author_name":"Juergen Maurer","author_inst":"University of Lausanne"},{"author_name":"Hans-Peter Kohler","author_inst":"University of Pennsylvania"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.07.138677","rel_title":"Structure Basis for Inhibition of SARS-CoV-2 by the Feline Drug GC376","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.07.138677","rel_abs":"The pandemic of SARS-CoV-2 coronavirus disease-2019 (COVID-19) caused by SARS-COV-2 continues to ravage many countries in the world. Mpro is an indispensable protein for viral translation in SARS-CoV-2 and a potential target in high-specificity anti-SARS-CoV-2 drug screening. In this study, to explore potential drugs for treating COVID-19, we elucidated the structure of SARS-CoV-2 Mpro and explored the interaction between Mpro and GC376, an antiviral drug used to treat a range of coronaviruses in Feline via inhibiting Mpro. The availability and safety of GC376 were proved by biochemical and cell experiments in vitro. We determined the structure of an important protein, Mpro, in SARS-CoV-2, and revealed the interaction of GC376 with the viral substrate and inhibition of the catalytic site of SARS-CoV-2 Mpro.","rel_num_authors":22,"rel_authors":[{"author_name":"Xiaodong Luan","author_inst":"School of Medicine, Tsinghua University; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Me"},{"author_name":"Weijuan Shang","author_inst":"Wuhan Institute of Virology, Chinese Academy of Sciences"},{"author_name":"Yifei Wang","author_inst":"School of Medicine, Tsinghua University"},{"author_name":"Wanchao Yin","author_inst":"Shanghai Institute of Materia Medica"},{"author_name":"Yi Jiang","author_inst":"Shanghai Institute of Materia Medica Chinese Academy of Sciences"},{"author_name":"Siqin Feng","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Yiyang Wang","author_inst":"School of Medicine, Tsinghua University"},{"author_name":"Meixi Liu","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Ruilin Zhou","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Zhiyu Zhang","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Feng Wang","author_inst":"Wuxi Biortus Biosciences Co. Ltd., 6"},{"author_name":"Cheng Wang","author_inst":"Wuxi Biortus Biosciences Co. Ltd., 6"},{"author_name":"Minqi Gao","author_inst":"Wuxi Biortus Biosciences Co. Ltd., 6"},{"author_name":"Hui Wang","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Wei Wu","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Ran Tian","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Zhuang Tian","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Ye Jin","author_inst":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences"},{"author_name":"Hualiang Jiang","author_inst":"Shanghai Institute of Materia Medica; University of Chinese Academy of Sciences"},{"author_name":"Leike Zhang","author_inst":"Wuhan Institute of Virology, Chinese Academy of Sciences"},{"author_name":"H. Eric Xu","author_inst":"Shanghai Institute of Materia Medica; University of Chinese Academy of Sciences"},{"author_name":"Shuyang Zhang","author_inst":"School of Medicine, Tsinghua University; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Me"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"biophysics"},{"rel_doi":"10.1101\/2020.06.05.134551","rel_title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.05.134551","rel_abs":"COVID-19 is an ongoing global crisis in which the development of effective vaccines and therapeutics will depend critically on understanding the natural immunity to the virus, including the role of SARS-CoV-2-specific T cells. We have conducted a study of 42 patients following recovery from COVID-19, including 28 mild and 14 severe cases, comparing their T cell responses to those of 16 control donors. We assessed the immune memory of T cell responses using IFN{gamma} based assays with overlapping peptides spanning SARS-CoV-2 apart from ORF1. We found the breadth, magnitude and frequency of memory T cell responses from COVID-19 were significantly higher in severe compared to mild COVID-19 cases, and this effect was most marked in response to spike, membrane, and ORF3a proteins. Total and spike-specific T cell responses correlated with the anti-Spike, anti-Receptor Binding Domain (RBD) as well as anti-Nucleoprotein (NP) endpoint antibody titre (p<0.001, <0.001 and =0.002). We identified 39 separate peptides containing CD4+ and\/or CD8+ epitopes, which strikingly included six immunodominant epitope clusters targeted by T cells in many donors, including 3 clusters in spike (recognised by 29%, 24%, 18% donors), two in the membrane protein (M, 32%, 47%) and one in the nucleoprotein (Np, 35%). CD8+ responses were further defined for their HLA restriction, including B*4001-restricted T cells showing central memory and effector memory phenotype. In mild cases, higher frequencies of multi-cytokine producing M- and NP-specific CD8+ T cells than spike-specific CD8+ T cells were observed. They furthermore showed a higher ratio of SARS-CoV-2-specific CD8+ to CD4+ T cell responses. Immunodominant epitope clusters and peptides containing T cell epitopes identified in this study will provide critical tools to study the role of virus-specific T cells in control and resolution of SARS-CoV-2 infections. The identification of T cell specificity and functionality associated with milder disease, highlights the potential importance of including non-spike proteins within future COVID-19 vaccine design.","rel_num_authors":60,"rel_authors":[{"author_name":"Tao Dong","author_inst":"Oxford University"},{"author_name":"Yanchun Peng","author_inst":"University of Oxford"},{"author_name":"Alexander J Mentzer","author_inst":"University of Oxford"},{"author_name":"Guihai Liu","author_inst":"University of Oxford"},{"author_name":"Xuan Yao","author_inst":"University of Oxford"},{"author_name":"Zixi Yin","author_inst":"University of Oxford"},{"author_name":"Danning Dong","author_inst":"University of Oxford"},{"author_name":"Wanwisa Dejnirattisai","author_inst":"University of Oxford"},{"author_name":"Lance Turtle","author_inst":"University of Liverpool"},{"author_name":"Timothy Rostron","author_inst":"University of Oxford"},{"author_name":"Krishanthi Subramaniam","author_inst":"University of Liverpool"},{"author_name":"Paul Thomson","author_inst":"University of Liverpool"},{"author_name":"Ping Zhang","author_inst":"University of Oxford"},{"author_name":"Christina Dold","author_inst":"University of Oxford"},{"author_name":"Jeremy Ratcliff","author_inst":"University of Oxford"},{"author_name":"Thushan de Silva","author_inst":"University of Sheffield"},{"author_name":"Paul Sopp","author_inst":"University of Oxford"},{"author_name":"Dannielle Wellington","author_inst":"University of Oxford"},{"author_name":"Ushani Rajapaksa","author_inst":"University of Oxford"},{"author_name":"Wayne Paes","author_inst":"University of Oxford"},{"author_name":"Persephone Borrow","author_inst":"University of Oxford"},{"author_name":"Benedikt M Kessler","author_inst":"University of Oxford"},{"author_name":"Jeremy W Fry","author_inst":"ProImmune Limited"},{"author_name":"Nikolai F Schwabe","author_inst":"ProImmune Limited"},{"author_name":"Malcolm G Semple","author_inst":"University of Liverpool"},{"author_name":"J Kenneth Baillie","author_inst":"Roslin Institute, University of Edinburgh"},{"author_name":"Peter JM Openshaw","author_inst":"Imperial College London"},{"author_name":"Richard J Cornall","author_inst":"University of Oxford"},{"author_name":"Chris Conlon","author_inst":"University of Oxford"},{"author_name":"Gavin Screaton","author_inst":"University of Oxford"},{"author_name":"Paul Klenerman","author_inst":"University of Oxford"},{"author_name":"Juthathip Mongkolsapaya","author_inst":"University of Oxford"},{"author_name":"Andrew McMichael","author_inst":"University of Oxford"},{"author_name":"Julian C Knight","author_inst":"University of Oxford"},{"author_name":"Graham Ogg","author_inst":"University of Oxford"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"new results","category":"immunology"},{"rel_doi":"10.1101\/2020.06.08.138826","rel_title":"SARS-CoV-2-specific T cells exhibit unique features characterized by robust helper function, lack of terminal differentiation, and high proliferative potential","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.08.138826","rel_abs":"Convalescing COVID-19 patients mount robust T cell responses against SARS-CoV-2, suggesting an important role for T cells in viral clearance. To date, the phenotypes of SARS-CoV-2-specific T cells remain poorly defined. Using 38-parameter CyTOF, we phenotyped longitudinal specimens of SARS-CoV-2-specific CD4+ and CD8+ T cells from nine individuals who recovered from mild COVID-19. SARS-CoV-2-specific CD4+ T cells were exclusively Th1 cells, and predominantly Tcm with phenotypic features of robust helper function. SARS-CoV-2-specific CD8+ T cells were predominantly Temra cells in a state of less terminal differentiation than most Temra cells. Subsets of SARS-CoV-2-specific T cells express CD127, can homeostatically proliferate, and can persist for over two months. Our results suggest that long-lived and robust T cell immunity is generated following natural SARS-CoV-2 infection, and support an important role for SARS-CoV-2-specific T cells in host control of COVID-19.","rel_num_authors":15,"rel_authors":[{"author_name":"Jason Neidleman","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Xiaoyu Luo","author_inst":"Gladstone Institutes"},{"author_name":"Julie Frouard","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Guorui Xie","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Gurjot Gill","author_inst":"University of California, San Francisco"},{"author_name":"Ellen S. Stein","author_inst":"University of California, San Francisco"},{"author_name":"Matthew McGregor","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Tongcui Ma","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Ashley George","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Astrid Kosters","author_inst":"Emory University"},{"author_name":"Warner C. Greene","author_inst":"Gladstone Institutes"},{"author_name":"Joshua Vasquez","author_inst":"University of California, San Francisco"},{"author_name":"Eliver Ghosn","author_inst":"Emory University"},{"author_name":"Sulggi Lee","author_inst":"University of California, San Francisco"},{"author_name":"Nadia R. Roan","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Thushan de Silva","author_inst":"University of Sheffield"},{"author_name":"Paul Sopp","author_inst":"University of Oxford"},{"author_name":"Dannielle Wellington","author_inst":"University of Oxford"},{"author_name":"Ushani Rajapaksa","author_inst":"University of Oxford"},{"author_name":"Wayne Paes","author_inst":"University of Oxford"},{"author_name":"Persephone Borrow","author_inst":"University of Oxford"},{"author_name":"Benedikt M Kessler","author_inst":"University of Oxford"},{"author_name":"Jeremy W Fry","author_inst":"ProImmune Limited"},{"author_name":"Nikolai F Schwabe","author_inst":"ProImmune Limited"},{"author_name":"Malcolm G Semple","author_inst":"University of Liverpool"},{"author_name":"J Kenneth Baillie","author_inst":"Roslin Institute, University of Edinburgh"},{"author_name":"Peter JM Openshaw","author_inst":"Imperial College London"},{"author_name":"Richard J Cornall","author_inst":"University of Oxford"},{"author_name":"Chris Conlon","author_inst":"University of Oxford"},{"author_name":"Gavin Screaton","author_inst":"University of Oxford"},{"author_name":"Paul Klenerman","author_inst":"University of Oxford"},{"author_name":"Juthathip Mongkolsapaya","author_inst":"University of Oxford"},{"author_name":"Andrew McMichael","author_inst":"University of Oxford"},{"author_name":"Julian C Knight","author_inst":"University of Oxford"},{"author_name":"Graham Ogg","author_inst":"University of Oxford"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"new results","category":"immunology"},{"rel_doi":"10.1101\/2020.06.08.140236","rel_title":"Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.08.140236","rel_abs":"Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has caused a pandemic of historic proportions and continues to spread globally, with enormous consequences to human health. Currently there is no vaccine, effective therapeutic or prophylactic. Like other betacoronaviruses, attachment and entry of SARS-CoV-2 is mediated by the spike glycoprotein (SGP). In addition to its well-documented interaction with its receptor, human angiotensin converting enzyme 2 (hACE2), SGP has been found to bind to glycosaminoglycans like heparan sulfate, which is found on the surface of virtually all mammalian cells. Here, we pseudotyped SARS-CoV-2 SGP on a third generation lentiviral (pLV) vector and tested the impact of various sulfated polysaccharides on transduction efficiency in mammalian cells. The pLV vector pseudotyped SGP efficiently and produced high titers on HEK293T cells. Various sulfated polysaccharides potently neutralized pLV-S pseudotyped virus with clear structure-based differences in anti-viral activity and affinity to SGP. Concentration-response curves showed that pLV-S particles were efficiently neutralized by a range of concentrations of unfractionated heparin (UFH), enoxaparin, 6-O-desulfated UFH and 6-O-desulfated enoxaparin with an IC50 of 5.99 {micro}g\/L, 1.08 mg\/L, 1.77 {micro}g\/L, and 5.86 mg\/L respectively. The low serum bioavailability of intranasally administered UFH, along with data suggesting that the nasal epithelium is a portal for initial infection and transmission, suggest that intranasal administration of UFH may be an effective and safe prophylactic treatment.","rel_num_authors":10,"rel_authors":[{"author_name":"Ritesh Tandon","author_inst":"University of Mississippi Medical Center"},{"author_name":"Joshua S. Sharp","author_inst":"University of Mississippi"},{"author_name":"Fuming Zhang","author_inst":"Rensselaer Polytechnic Institute"},{"author_name":"Vitor H. Pomin","author_inst":"University of Mississippi"},{"author_name":"Nicole M. Ashpole","author_inst":"University of Mississippi"},{"author_name":"Dipanwita Mitra","author_inst":"University of Mississippi Medical Center"},{"author_name":"Weihua Jin","author_inst":"Rensselaer Polytechnic Institute"},{"author_name":"Hao Liu","author_inst":"University of Mississippi"},{"author_name":"Poonam Sharma","author_inst":"University of Mississippi Medical Center"},{"author_name":"Robert J. Linhardt","author_inst":"Rensselaer Polytechnic Institute"},{"author_name":"Warner C. Greene","author_inst":"Gladstone Institutes"},{"author_name":"Joshua Vasquez","author_inst":"University of California, San Francisco"},{"author_name":"Eliver Ghosn","author_inst":"Emory University"},{"author_name":"Sulggi Lee","author_inst":"University of California, San Francisco"},{"author_name":"Nadia R. Roan","author_inst":"University of California, San Francisco; and Gladstone Institutes"},{"author_name":"Thushan de Silva","author_inst":"University of Sheffield"},{"author_name":"Paul Sopp","author_inst":"University of Oxford"},{"author_name":"Dannielle Wellington","author_inst":"University of Oxford"},{"author_name":"Ushani Rajapaksa","author_inst":"University of Oxford"},{"author_name":"Wayne Paes","author_inst":"University of Oxford"},{"author_name":"Persephone Borrow","author_inst":"University of Oxford"},{"author_name":"Benedikt M Kessler","author_inst":"University of Oxford"},{"author_name":"Jeremy W Fry","author_inst":"ProImmune Limited"},{"author_name":"Nikolai F Schwabe","author_inst":"ProImmune Limited"},{"author_name":"Malcolm G Semple","author_inst":"University of Liverpool"},{"author_name":"J Kenneth Baillie","author_inst":"Roslin Institute, University of Edinburgh"},{"author_name":"Peter JM Openshaw","author_inst":"Imperial College London"},{"author_name":"Richard J Cornall","author_inst":"University of Oxford"},{"author_name":"Chris Conlon","author_inst":"University of Oxford"},{"author_name":"Gavin Screaton","author_inst":"University of Oxford"},{"author_name":"Paul Klenerman","author_inst":"University of Oxford"},{"author_name":"Juthathip Mongkolsapaya","author_inst":"University of Oxford"},{"author_name":"Andrew McMichael","author_inst":"University of Oxford"},{"author_name":"Julian C Knight","author_inst":"University of Oxford"},{"author_name":"Graham Ogg","author_inst":"University of Oxford"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.06.08.140244","rel_title":"Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.08.140244","rel_abs":"The SARS-CoV-2 virus is responsible for the current worldwide coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing hundreds of thousands of deaths. The Spike glycoprotein of SARS-CoV-2 mediates viral entry and is the main target for neutralizing antibodies. Understanding the antibody response directed against SARS-CoV-2 is crucial for the development of vaccine, therapeutic and public health interventions. Here we performed a cross-sectional study on 106 SARS-CoV-2-infected individuals to evaluate humoral responses against the SARS-CoV-2 Spike. The vast majority of infected individuals elicited anti-Spike antibodies within 2 weeks after the onset of symptoms. The levels of receptor-binding domain (RBD)-specific IgG persisted overtime, while the levels of anti-RBD IgM decreased after symptoms resolution. Some of the elicited antibodies cross-reacted with other human coronaviruses in a genus-restrictive manner. While most of individuals developed neutralizing antibodies within the first two weeks of infection, the level of neutralizing activity was significantly decreased over time. Our results highlight the importance of studying the persistence of neutralizing activity upon natural SARS-CoV-2 infection.","rel_num_authors":35,"rel_authors":[{"author_name":"Jeremie Prevost","author_inst":"Universite de Montreal"},{"author_name":"Romain Gasser","author_inst":"Universite de Montreal"},{"author_name":"Guillaume Beaudoin-Bussieres","author_inst":"Universite de Montreal"},{"author_name":"Jonathan Richard","author_inst":"CRCHUM"},{"author_name":"Ralf Duerr","author_inst":"New York University"},{"author_name":"Annemarie Laumaea","author_inst":"Universite de Montreal"},{"author_name":"Sai Priya Anand","author_inst":"McGill University"},{"author_name":"Guillaume Goyette","author_inst":"CRCHUM"},{"author_name":"Mehdi Benlarbi","author_inst":"CRCHUM"},{"author_name":"Shilei Ding","author_inst":"Universite de Montreal"},{"author_name":"Halima Medjahed","author_inst":"CRCHUM"},{"author_name":"Antoine Lewin","author_inst":"Hema-Quebec"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.06.06.138339","rel_title":"SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.06.138339","rel_abs":"BackgroundWith the gradual reopening of economies and resumption of social life, robust surveillance mechanisms should be implemented to control the ongoing COVID-19 pandemic. Unlike RT-qPCR, SARS-CoV-2 Whole Genome Sequencing (cWGS) has the added advantage of identifying cryptic origins of the virus, and the extent of community-based transmissions versus new viral introductions, which can in turn influence public health policy decisions. However, practical and cost considerations of cWGS should be addressed before it can be widely implemented.\n\nMethodsWe performed shotgun transcriptome sequencing using RNA extracted from nasopharyngeal swabs of patients with COVID-19, and compared it to targeted SARS-CoV-2 full genome amplification and sequencing with respect to virus detection, scalability, and cost-effectiveness. To track virus origin, we used open-source multiple sequence alignment and phylogenetic tools to compare the assembled SARS-CoV-2 genomes to publicly available sequences.\n\nResultsWe show a significant improvement in whole genome sequencing data quality and viral detection using amplicon-based target enrichment of SARS-CoV-2. With enrichment, more than 99% of the sequencing reads mapped to the viral genome compared to an average of 0.63% without enrichment. Consequently, a dramatic increase in genome coverage was obtained using significantly less sequencing data, enabling higher scalability and significant cost reductions. We also demonstrate how SARS-CoV-2 genome sequences can be used to determine their possible origin through phylogenetic analysis including other viral strains.\n\nConclusionsSARS-CoV-2 whole genome sequencing is a practical, cost-effective, and powerful approach for population-based surveillance and control of viral transmission in the next phase of the COVID-19 pandemic.","rel_num_authors":11,"rel_authors":[{"author_name":"Divinlal Harilal","author_inst":"Al Jalila Genomics Center, Al Jalila Childrens Hospital, Dubai, United Arab Emirates"},{"author_name":"Sathishkumar Ramaswamy","author_inst":"Al Jalila Genomics Center, Al Jalila Childrens Hospital, Dubai, United Arab Emirates"},{"author_name":"Tom Loney","author_inst":"College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates."},{"author_name":"Hanan Alsuwaidi","author_inst":"Mohammed Bin Rashid University of Medicine and Health Sciences"},{"author_name":"Hamda Khansaheb","author_inst":"Dubai Health Authority"},{"author_name":"Abdulmajeed AlKhajeh","author_inst":"Dubai Health Authority"},{"author_name":"Rupa Varghese","author_inst":"Microbiology and Infection Control Unit, Pathology and Genetics Department, Latifa Women and Children Hospital, Dubai Health Authority, Dubai, United Arab Emira"},{"author_name":"Zulfa Deesi","author_inst":"Microbiology and Infection Control Unit, Pathology and Genetics Department, Latifa Women and Children Hospital, Dubai Health Authority, Dubai, United Arab Emira"},{"author_name":"Norbert Nowotny","author_inst":"Institute of Virology, University of Veterinary Medicine Vienna, Vienna, Austria."},{"author_name":"Alawi Alsheikh-Ali","author_inst":"College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates."},{"author_name":"Ahmad Abou Tayoun","author_inst":"Al Jalila Genomics Center, Al Jalila Childrens Hospital, and College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United "},{"author_name":"Antoine Lewin","author_inst":"Hema-Quebec"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"genomics"},{"rel_doi":"10.1101\/2020.06.08.137331","rel_title":"Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.08.137331","rel_abs":"Angiotensin-converting enzyme 2 (ACE2), a component of the renin-angiotensin system, is a receptor for SARS-CoV-2, the virus that causes COVID-19. To determine whether the renin-angiotensin inhibition regulates ACE2 expression, either enalapril (an angiotensin-converting enzyme inhibitor) or losartan (an AT1 receptor blocker) was infused subcutaneously to male C57BL\/6J mice for two weeks. Neither enalapril nor losartan changed abundance of ACE2 mRNA in lung, ileum, kidney, and heart. Viral entry also depends on transmembrane protease serine 2 (TMPRSS2) to prime the S protein. TMPRSS2 mRNA was abundant in lungs and ileum, modest in kidney, but barely detectable in heart. TMPRSS2 mRNA abundance was not altered by either enalapril or losartan in any of the 4 tissues. Next, we determined whether depletion of angiotensinogen (AGT), the unique substrate of the renin-angiotensin system, changes ACE2 and TMPRSS2 mRNA abundance. AGT antisense oligonucleotides (ASO) were injected subcutaneously to male C57BL\/6J mice for 3 weeks. Abundance of ACE2 mRNA was unchanged in any of the 4 tissues, but TMPRSS2 mRNA was significantly decreased in lungs. Our data support that the renin-angiotensin inhibition does not regulate ACE2 and hence are not likely to increase risk for COVID-19.","rel_num_authors":7,"rel_authors":[{"author_name":"Congqing Wu","author_inst":"University of Kentucky"},{"author_name":"Dien Ye","author_inst":"University of Kentucky"},{"author_name":"Adam E Mullick","author_inst":"Ionis"},{"author_name":"Zhenyu Li","author_inst":"University of Kentucky"},{"author_name":"A.H. Jan Danser","author_inst":"Erasmus MC"},{"author_name":"Alan Daugherty","author_inst":"University of Kentucky"},{"author_name":"Hong S. Lu","author_inst":"University of Kentucky"},{"author_name":"Zulfa Deesi","author_inst":"Microbiology and Infection Control Unit, Pathology and Genetics Department, Latifa Women and Children Hospital, Dubai Health Authority, Dubai, United Arab Emira"},{"author_name":"Norbert Nowotny","author_inst":"Institute of Virology, University of Veterinary Medicine Vienna, Vienna, Austria."},{"author_name":"Alawi Alsheikh-Ali","author_inst":"College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates."},{"author_name":"Ahmad Abou Tayoun","author_inst":"Al Jalila Genomics Center, Al Jalila Childrens Hospital, and College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United "},{"author_name":"Antoine Lewin","author_inst":"Hema-Quebec"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"new results","category":"molecular biology"},{"rel_doi":"10.1101\/2020.06.08.140459","rel_title":"Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide","rel_date":"2020-06-08","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.06.08.140459","rel_abs":"The COVID-19 pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared on March 11, 2020 by the World Health Organization. As of the 31st of May, 2020, there have been more than 6 million COVID-19 cases diagnosed worldwide and over 370,000 deaths, according to Johns Hopkins. Thousands of SARS-CoV-2 strains have been sequenced to date, providing a valuable opportunity to investigate the evolution of the virus on a global scale. We performed a phylogenetic analysis of over 1,225 SARS-CoV-2 genomes spanning from late December 2019 to mid-March 2020. We identified a missense mutation, D614G, in the spike protein of SARS-CoV-2, which has emerged as a predominant clade in Europe (954 of 1,449 (66%) sequences) and is spreading worldwide (1,237 of 2,795 (44%) sequences). Molecular dating analysis estimated the emergence of this clade around mid-to-late January (10 - 25 January) 2020. We also applied structural bioinformatics to assess D614G potential impact on the virulence and epidemiology of SARS-CoV-2. In silico analyses on the spike protein structure suggests that the mutation is most likely neutral to protein function as it relates to its interaction with the human ACE2 receptor. The lack of clinical metadata available prevented our investigation of association between viral clade and disease severity phenotype. Future work that can leverage clinical outcome data with both viral and human genomic diversity is needed to monitor the pandemic.","rel_num_authors":12,"rel_authors":[{"author_name":"Sandra Isabel","author_inst":"The Hospital for Sick Children"},{"author_name":"Lucia Grana-Miraglia","author_inst":"University of Toronto"},{"author_name":"Jahir M Gutierrez","author_inst":"Layer 6 AI"},{"author_name":"Cedoljub Bundalovic-Torma","author_inst":"University of Toronto"},{"author_name":"Helen E Groves","author_inst":"University of Toronto"},{"author_name":"Marc R Isabel","author_inst":"Universite Laval"},{"author_name":"Alireza Eshaghi","author_inst":"Public Health Ontario"},{"author_name":"Samir N Patel","author_inst":"Public Health Ontario"},{"author_name":"Jonathan B Gubbay","author_inst":"Publich Health Ontario"},{"author_name":"Tomi Poutanen","author_inst":"Layer 6 AI"},{"author_name":"David S Guttman","author_inst":"University of Toronto"},{"author_name":"Susan M Poutanen","author_inst":"University of Toronto"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"new results","category":"bioinformatics"},{"rel_doi":"10.1101\/2020.06.05.20123711","rel_title":"Prevention of household transmission crucial to stop the catastrophic spread of COVID-19 in cities","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123711","rel_abs":"After weeks under lockdown, metropolitan areas fighting the spread of COVID-19 aim to balance public health goals with social and economic standards for well-being. Mathematical models of disease transmission seeking to evaluate mitigation strategies must assess the possible impacts of social distancing, economic lockdowns and other measures. However, obscure relations between model parameters and real-world phenomena complicate such analyses. Here, we use a high-resolution metapopulation model of Guadalajara (GDL, Western Mexico) to represent daily mobility patterns driven by economic activities and their relation to epidemic growth. Given the prominence of essential activities in the city's economy, we find that strategies aiming to mitigate the risk of out-of-home interactions are insufficient to stop the catastrophic spread of COVID-19. Using baseline reproduction numbers R0 = [2.5, 3.0] in the absence of interventions, our simulations suggest that household transmission alone can make Rt ~ 1, and is estimated to drive 70 {+\/-} 15% of current epidemic growth. This sets an upper bound for the impact of mobility-based interventions, which are unlikely to lower Rt below 1.3 and must be complemented with aggressive campaigns for early case detection and isolation. As laboratory testing and health services become insufficient to meet demand in GDL and most other cities, we propose that cities facilitate guidelines and equipment to help people curb spreading within their own homes. Postponing these actions will increase their economic cost and decrease their potential returns.","rel_num_authors":11,"rel_authors":[{"author_name":"Noel Gutierrez Brizuela","author_inst":"University of California, San Diego"},{"author_name":"Humberto Gutierrez Pulido","author_inst":"Universidad de Guadalajara"},{"author_name":"Kimberlyn Roosa","author_inst":"Georgia State University"},{"author_name":"Nestor Garcia Chan","author_inst":"Universidad de Guadalajara"},{"author_name":"Jorge Hernandez-Bello","author_inst":"Universidad de Guadalajara"},{"author_name":"Jose Francisco Munoz-Valle","author_inst":"Universidad de Guadalajara"},{"author_name":"Gabriela Macedo-Ojeda","author_inst":"Universidad de Guadalajara"},{"author_name":"Javier Alonso Lopez-Chavez","author_inst":"Universidad de Guadalajara"},{"author_name":"Guillermo Gonzalez Estevez","author_inst":"Universidad de Guadalajara"},{"author_name":"Ricardo Villanueva Lomeli","author_inst":"Universidad de Guadalajara"},{"author_name":"Gerardo Chowell","author_inst":"Georgia State University School of Public Health"},{"author_name":"Susan M Poutanen","author_inst":"University of Toronto"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.06.06.20123893","rel_title":"Public health interventions in India slowed the spread of COVID-19 epidemic dynamics","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.06.20123893","rel_abs":"Background The government of India implemented social distancing interventions to contain the COVID-19 epidemic. However, effects on epidemic dynamics are yet to be understood. Methods Rates of laboratory-confirmed COVID-19 infections per day and effective reproduction number (Rt) were estimated for 4 periods (Pre-lockdown and Lockdown Phases 1 to 3) according to nationally implemented phased interventions. Adoption of these interventions was estimated using Google mobility data. Estimates at the national level and for 12 Indian states most affected by COVID-19 are presented. Findings Daily case rates ranged from 0.03 to 30.05\/10 million people across 4 discrete periods in India. From May 4-17, 2020, the National Capital Territory (NCT) of Delhi had the highest case rate (222\/10 million people\/day), whereas Kerala had the lowest (2.18\/10 million\/day). Average Rt was 1.99 (95% CI 1.93-2.06) for India; it ranged from 1.38 to 2.78, decreasing over time. Median mobility in India decreased in all contact domains, with the lowest being 21% in retail\/recreation (95% CI 13-46%), except home which increased to 129% (95% CI 117-132%) compared to the 100% baseline value. Interpretation The Indian government imposed strict contact mitigation, followed by a phased relaxation, which slowed the spread of COVID-19 epidemic progression in India. The identified daily COVID-19 case rates and Rt will aid national and state governments in formulating ongoing COVID-19 containment plans. Furthermore, these findings may inform COVID-19 public health policy in developing countries with similar settings to India. Funding Non-funded.","rel_num_authors":8,"rel_authors":[{"author_name":"Balbir Bagicha Singh","author_inst":"Guru Angad Dev Veterinary & Animal Sciences University"},{"author_name":"Mark Lowerison","author_inst":"Dept. of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Ryan T Lewinson","author_inst":"Dept. of Medicine, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Isabelle A Vallerand","author_inst":"Dept. of Medicine, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Rob Deardon","author_inst":"Dept. of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Jatinder PS Gill","author_inst":"Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab 141004, India"},{"author_name":"Baljit Singh Gill","author_inst":"One Health at UCalgary, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Herman W Barkema","author_inst":"One Health at UCalgary, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Guillermo Gonzalez Estevez","author_inst":"Universidad de Guadalajara"},{"author_name":"Ricardo Villanueva Lomeli","author_inst":"Universidad de Guadalajara"},{"author_name":"Gerardo Chowell","author_inst":"Georgia State University School of Public Health"},{"author_name":"Susan M Poutanen","author_inst":"University of Toronto"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.06.05.20123703","rel_title":"Evaluation of Knowledge, Practices, Attitude and Anxiety of Pakistans Nurses towards COVID-19 during the Current Outbreak in Pakistan","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123703","rel_abs":"Since the emergence of novel corona virus the front line soldiers during this pandemic are the healthcare professionals because of their direct association with the patients. In the management of COVID-19 patient nurses play a significant role through proper care and preventive measures. Due to the contagious nature, fatality and no proper medicine, it is a risk to the health and life of nurses and has impact on their psychological health. In the current study we accessed the knowledge, attitude, practices and anxiety levels of the nurses who are directly involved in the management of COVID-19 patients. It was an online questionnaire based cross sectional survey targeted only those only nurses involved in the management of COVID-19 patients from different hospitals of Karachi, Pakistan. SPSS 21 was used for data analysis. Descriptive analysis, Chi Square and t-tests were applied. Value <0.05 was considered significant. Data of 78 nurses were analyzed .We observed that nurses possess good knowledge about COVID-19, its sources, symptoms, routes of transmission of virus and etc. The knowledge mean score was calculated 14.67 {+\/-} 3.36. Health department \/Hospital and social media are the main sources of information regarding COVID-19. We investigated that 92.3% of the nurses had mild to very severe anxiety and anxiety levels are significantly higher among the females (P<0.05). We conclude that the nurses performing their duties with COVID-19 positive patients have good knowledge and attitude. But their anxiety levels are high. Psychological interventions along with training should be given.","rel_num_authors":7,"rel_authors":[{"author_name":"Shaheena Salman Alwani","author_inst":"Liaquat National Hospital and Medical College, Karachi, Pakistan"},{"author_name":"Muhammad Mansoor Majeed","author_inst":"Department of Oral Biology, Altamash Institute of Dental Medicine, Karachi, Pakistan."},{"author_name":"Monia Zeeshan Hirwani","author_inst":"Aga Khan University Hospital, Karachi, Pakistan"},{"author_name":"Shahzad Rauf","author_inst":"Department of Psychiatry ,Bahria University Medical & Dental College, Karachi, Pakistan."},{"author_name":"Syed Muhammad Saad","author_inst":"Layton Rahmatulla Benevolent Trust Hospital, Karachi, Pakistan"},{"author_name":"Sheikh Haroon Shah","author_inst":"Liaquat National Hospital,  Karachi, Pakistan"},{"author_name":"Faiq Munir Hamirani","author_inst":"Metro health System, Cleveland, USA"},{"author_name":"Herman W Barkema","author_inst":"One Health at UCalgary, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Guillermo Gonzalez Estevez","author_inst":"Universidad de Guadalajara"},{"author_name":"Ricardo Villanueva Lomeli","author_inst":"Universidad de Guadalajara"},{"author_name":"Gerardo Chowell","author_inst":"Georgia State University School of Public Health"},{"author_name":"Susan M Poutanen","author_inst":"University of Toronto"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"nursing"},{"rel_doi":"10.1101\/2020.06.05.20123356","rel_title":"On the Spread of Coronavirus Infection. A Mechanistic Model to Rate Strategies for Disease Management","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123356","rel_abs":"Effective policy making based on ongoing COVID-19 pandemic is an urgent issue. We present a mathematical model describing the viral infection dynamics, which reveals two transmissibility parameters influenced by the management strategies in the area for control of the current pandemic. The parameters readily yield the peak infection rate and means for flattening the curve. Model parameters are shown to be correlated to different management strategies by employing machine learning enabling the comparison among different strategies. Treatment of population data with the model shows that restricted non-essential business closure, school closing and strictures on mass gathering influence the spread of infection. While a rational strategy for initiation of an economic reboot would call for a wider perspective of the local economics, the model can speculate on its timing based on the status of the infection as reflected by its potential for an unacceptably renewed viral onslaught.","rel_num_authors":2,"rel_authors":[{"author_name":"Shiyan Wang","author_inst":"Purdue University"},{"author_name":"Doraiswami Ramkrishna","author_inst":"Purdue University"},{"author_name":"Monia Zeeshan Hirwani","author_inst":"Aga Khan University Hospital, Karachi, Pakistan"},{"author_name":"Shahzad Rauf","author_inst":"Department of Psychiatry ,Bahria University Medical & Dental College, Karachi, Pakistan."},{"author_name":"Syed Muhammad Saad","author_inst":"Layton Rahmatulla Benevolent Trust Hospital, Karachi, Pakistan"},{"author_name":"Sheikh Haroon Shah","author_inst":"Liaquat National Hospital,  Karachi, Pakistan"},{"author_name":"Faiq Munir Hamirani","author_inst":"Metro health System, Cleveland, USA"},{"author_name":"Herman W Barkema","author_inst":"One Health at UCalgary, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Guillermo Gonzalez Estevez","author_inst":"Universidad de Guadalajara"},{"author_name":"Ricardo Villanueva Lomeli","author_inst":"Universidad de Guadalajara"},{"author_name":"Gerardo Chowell","author_inst":"Georgia State University School of Public Health"},{"author_name":"Susan M Poutanen","author_inst":"University of Toronto"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"health policy"},{"rel_doi":"10.1101\/2020.06.05.20123380","rel_title":"COVID 19 healthcare facility demand forecasts for rural residents","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123380","rel_abs":"One of the main challenges in dealing with the current COVID 19 pandemic is how to fulfill the healthcare facility demands especially for the residents living in the rural areas that have restricted healthcare access. Correspondingly, this study aims to record the daily COVID 19 cases and continue with the forecasting of the average daily demand (ADD) of healthcare facilities including beds, ICUs, and ventilators using ARIMA model. The forecasts were made for 3 rural populations located in the southern Amazon. The model shows that the healthcare ADD was different in each population. Likewise, the model forecasts that in a rural population that has the highest daily case with projected average cases equal to 67 cases\/day (95%CI: 24, 110), that population has to fulfill healthcare ADD consisting of 57 beds\/day (95%CI: 21, 93), 8 ICUs\/day (95%CI: 2, 14), and 2 ventilators\/day (95%CI: 2, 3). To conclude, the ARIMA model has addressed critical questions about ADD for beds, ICUs, and ventilators for rural residents. This ARIMA model based healthcare plan will hopefully provide versatile tool to improve healthcare resource allocations.","rel_num_authors":1,"rel_authors":[{"author_name":"Andrio Adwibowo","author_inst":"University of Indonesia"},{"author_name":"Doraiswami Ramkrishna","author_inst":"Purdue University"},{"author_name":"Monia Zeeshan Hirwani","author_inst":"Aga Khan University Hospital, Karachi, Pakistan"},{"author_name":"Shahzad Rauf","author_inst":"Department of Psychiatry ,Bahria University Medical & Dental College, Karachi, Pakistan."},{"author_name":"Syed Muhammad Saad","author_inst":"Layton Rahmatulla Benevolent Trust Hospital, Karachi, Pakistan"},{"author_name":"Sheikh Haroon Shah","author_inst":"Liaquat National Hospital,  Karachi, Pakistan"},{"author_name":"Faiq Munir Hamirani","author_inst":"Metro health System, Cleveland, USA"},{"author_name":"Herman W Barkema","author_inst":"One Health at UCalgary, University of Calgary, 3330 Hospital Drive NW, Calgary, Canada, T2N 4N1"},{"author_name":"Guillermo Gonzalez Estevez","author_inst":"Universidad de Guadalajara"},{"author_name":"Ricardo Villanueva Lomeli","author_inst":"Universidad de Guadalajara"},{"author_name":"Gerardo Chowell","author_inst":"Georgia State University School of Public Health"},{"author_name":"Susan M Poutanen","author_inst":"University of Toronto"},{"author_name":"Josee Perreault","author_inst":"Hema-Quebec"},{"author_name":"Tony Tremblay","author_inst":"Hema-Quebec"},{"author_name":"Gabrielle Gendron-Lepage","author_inst":"CRCHUM"},{"author_name":"Nicolas Gauthier","author_inst":"Hopital Sacre-Coeur de Montreal"},{"author_name":"Marc Carrier","author_inst":"Hopital Cite-de-la-Sante"},{"author_name":"Diane Marcoux","author_inst":"Hotel-Dieu de Levis"},{"author_name":"Alain Piche","author_inst":"CHU Sherbrooke"},{"author_name":"Myriam Lavoie","author_inst":"Hopital de Chicoutimi"},{"author_name":"Alexandre Benoit","author_inst":"Hoptial de Verdun"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"health systems and quality improvement"},{"rel_doi":"10.1101\/2020.06.05.20123117","rel_title":"Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123117","rel_abs":"Background. During the COVID-19 outbreak, reports have surfaced of children who present with features of a multisystem inflammatory syndrome with overlapping features of Kawasaki disease and toxic shock syndrome - Paediatric Inflammatory Multisystem Syndrome- temporally associated with SARS-CoV-2 pandemic (PIMS-TS). Initial reports find that many of the children are PCR-negative for SARS-CoV-2, so it is difficult to confirm whether this syndrome is a late complication of viral infection in an age group largely spared the worst consequences of this infection, or if this syndrome reflects enhanced surveillance. Methods. Children hospitalised for symptoms consistent with PIMS-TS between 28 April and 8 May 2020, and who were PCR-negative for SARS-CoV-2, were tested for antibodies to viral spike glycoprotein using an ELISA test. Results. Eight patients (age range 7-14 years, 63% male) fulfilled case-definition for PIMS-TS during the study period. Six of the eight patients required admission to intensive care. All patients exhibited significant IgG and IgA responses to viral spike glycoprotein. Further assessment showed that the IgG isotypes detected in children with PIMS-TS were of the IgG1 and IgG3 subclasses, a distribution similar to that observed in samples from hospitalised adult COVID-19 patients. In contrast, IgG2 and IgG4 were not detected in children or adults. IgM was not detected in children, which contrasts with adult hospitalised adult COVID-19 patients of whom all had positive IgM responses. Conclusions. Strong IgG antibody responses can be detected in PCR-negative children with PIMS-TS. The low detection rate of IgM in these patients is consistent with infection having occurred weeks previously and that the syndrome onset occurs well after the control of SARS-CoV-2 viral load. This implies that the disease is largely immune-mediated. Lastly, this indicates that serology can be an appropriate diagnostic tool in select patient groups.","rel_num_authors":21,"rel_authors":[{"author_name":"Marisol Perez-Toledo","author_inst":"University of Birmingham"},{"author_name":"Sian E. Faustini","author_inst":"University of Birmingham"},{"author_name":"Sian E. Jossi","author_inst":"University of Birmingham"},{"author_name":"Adrian Shields","author_inst":"University of Birmingham"},{"author_name":"Hari Krishnan Kanthimathinathan","author_inst":"Birmingham Women and Children's NHS Foundation Trust"},{"author_name":"Joel D. Allen","author_inst":"University of Southampton"},{"author_name":"Yasunori Watanabe","author_inst":"University of Southampton"},{"author_name":"Margaret Goodall","author_inst":"University of Birmingham"},{"author_name":"David C. Wraith","author_inst":"University of Birmingham"},{"author_name":"Tonny V. Veenith","author_inst":"University Hospitals Birmingham NHS Trust"},{"author_name":"Mark T. Drayson","author_inst":"University of Birmingham"},{"author_name":"Deepthi Jyothish","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Eslam Al-Abadi","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Ashish Chikermane","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.05.20123745","rel_title":"Combined oropharyngeal\/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123745","rel_abs":"Background: Early 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal\/nasal (OP\/N) sampling method was investigated using the more readily available throat swab. Methods: In this prospective observational study 36 COVID-19 patients were tested with both a NP and combined OP\/N swab for SARS-CoV-2 RNA by PCR. In hospitalized suspect patients, who tested negative on both swabs, extensive retesting was performed. The sensitivity of NP versus combined OP\/N swab sampling on admission and the correlation between viral RNA loads recovered was investigated. Results: 35 patients were diagnosed with SARS-CoV-2 by means of either NP or OP\/N sampling. The paired swabs were both positive in 31 patients. The one patient who tested negative on both NP and OP\/N swab on admission, was ultimately diagnosed on bronchoalveolar lavage fluid. A strong correlation was found between the viral RNA loads of the paired swabs (r = 0.76; P < 0.05). The sensitivity of NP and OP\/N analysis in hospitalized patients (n = 28) was 89.3% and 92.7% respectively. Conclusions: This study demonstrates equivalence of NP and OP\/N sampling for detection of SARS-CoV-2 by means of rRT-PCR. Sensitivity of both NP and OP\/N sampling is very high in hospitalized patients.","rel_num_authors":13,"rel_authors":[{"author_name":"Tania Desmet","author_inst":"Ghent University Hospital"},{"author_name":"Peter De Paepe","author_inst":"Ghent University Hospital"},{"author_name":"Jerina Boelens","author_inst":"Ghent University Hospital"},{"author_name":"Liselotte Coorevits","author_inst":"Ghent University Hospital"},{"author_name":"Elizaveta Padalko","author_inst":"Ghent University Hospital"},{"author_name":"Stien Vandendriessche","author_inst":"Ghent University Hospital"},{"author_name":"Isabel Leroux-Roels","author_inst":"Ghent University Hospital"},{"author_name":"Annelies Aerssens","author_inst":"Ghent University Hospital"},{"author_name":"Steven Callens","author_inst":"Ghent University Hospital"},{"author_name":"Eva Van Braeckel","author_inst":"Ghent University Hospital"},{"author_name":"Thomas Malfait","author_inst":"Ghent University Hospital"},{"author_name":"Frank Vermassen","author_inst":"Ghent University Hospital"},{"author_name":"Bruno Verhasselt","author_inst":"Ghent University Hospital"},{"author_name":"Ashish Chikermane","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.05.20123349","rel_title":"An environmental determinant of viral respiratory disease","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123349","rel_abs":"The evident seasonality of influenza suggests a significant role for weather and climate as one of several determinants of viral respiratory disease (VRD), including social determinants which play a major role in shaping these phenomena. Based on the current mechanistic understanding of how VRDs are transmitted by small droplets, we identify an environmental variable, Air Drying Capacity (ADC), as an atmospheric state-variable with significant and direct relevance to the transmission of VRD. ADC dictates the evolution and fate of droplets under given temperature and humidity conditions. The definition of this variable is rooted in the Maxwell theory of droplet evolution via coupled heat and mass transfer between droplets and the surrounding environment. We present the climatology of ADC, and compare its observed distribution in space and time to the observed prevalence of influenza and COVID-19 from extensive global data sets. Globally, large ADC values appear to significantly constrain the observed transmission and spread of VRD, consistent with the significant coherency of the observed seasonal cycles of ADC and influenza. Our results introduce a new environmental determinant, rooted in the mechanism of VRD transmission, with potential implications for explaining seasonality of influenza, and for describing how environmental conditions may impact to some degree the evolution of similar VRDs, such as COVID-19.","rel_num_authors":3,"rel_authors":[{"author_name":"Yeon-Woo Choi","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Alexandre Tuel","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Elfatih A. B. Eltahir","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Liselotte Coorevits","author_inst":"Ghent University Hospital"},{"author_name":"Elizaveta Padalko","author_inst":"Ghent University Hospital"},{"author_name":"Stien Vandendriessche","author_inst":"Ghent University Hospital"},{"author_name":"Isabel Leroux-Roels","author_inst":"Ghent University Hospital"},{"author_name":"Annelies Aerssens","author_inst":"Ghent University Hospital"},{"author_name":"Steven Callens","author_inst":"Ghent University Hospital"},{"author_name":"Eva Van Braeckel","author_inst":"Ghent University Hospital"},{"author_name":"Thomas Malfait","author_inst":"Ghent University Hospital"},{"author_name":"Frank Vermassen","author_inst":"Ghent University Hospital"},{"author_name":"Bruno Verhasselt","author_inst":"Ghent University Hospital"},{"author_name":"Ashish Chikermane","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.05.20123471","rel_title":"Symptom Course in COVID-19 Outpatients","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123471","rel_abs":"Objective: Describe the disease course in a cohort of outpatients with covid-19 and evaluate factors predicting duration of symptoms Design: Retrospective cohort study Setting: Telemedicine clinic at a large medical system in Atlanta, Georgia Participants: 273 patients with COVID-19. Exclusion criteria included: (1) intake more than 10 days after symptom onset, (2) hospitalization for covid-19, (3) symptoms at less than two visits. Main outcome measures: Symptom duration in days Results: Common symptoms at diagnosis are upper respiratory (64% cough, 53% loss of smell or taste, 50% sinus congestion, 22% sore throat), systemic (50% headache, 48% body aches, 36% chills, 22% dizziness, 18% fever). The most frequent remaining symptoms at 30 days were cough (7%), loss of smell or taste (5%), body aches (5%), nasal congestion (5%), shortness of breath with exertion (5%), and joint pain (5%). Day of symptom onset was earliest for upper respiratory symptoms (mean 1.26 days, 95% confidence interval 1.15 to 1.4), followed by systemic symptoms (1.54, 1.39 to 1.7), with later onset of lower respiratory (2.86, 2.54 to 3.22) and gastrointestinal symptoms (3.46, 3.07 to 3.89), when present. Cough had the longest duration when present with 12.2 days (10.9 to 13.6). Loss of smell or taste had the second longest duration with 11.0 days (9.9 to 12.2). Provider-Assessed Symptom Severity (PASS) is the best predictor of symptom duration (P <0.005 for multiple symptoms) and patients with Moderate PASS compared to Mild at their intake visit have higher rates of symptoms at 30 days, including cough (12%), nasal congestion (10%), joint pain (10%), body aches (9%), loss of taste or smell (7%), headache (7%), and shortness of breath with exertion (6%). Conclusions: Covid-19 illness in outpatients follows a pattern of progression from systemic symptoms to lower respiratory symptoms and persistent symptoms are common across categories. Provider-assessed symptom severity is the best predictor of disease duration.","rel_num_authors":4,"rel_authors":[{"author_name":"James B O'Keefe","author_inst":"Emory University School of Medicine"},{"author_name":"Elizabeth J Tong","author_inst":"Emory University School of Medicine"},{"author_name":"Ghazala A Datoo O'Keefe","author_inst":"Emory University School of Medicine"},{"author_name":"David C Tong","author_inst":"Emory University School of Medicine"},{"author_name":"Elizaveta Padalko","author_inst":"Ghent University Hospital"},{"author_name":"Stien Vandendriessche","author_inst":"Ghent University Hospital"},{"author_name":"Isabel Leroux-Roels","author_inst":"Ghent University Hospital"},{"author_name":"Annelies Aerssens","author_inst":"Ghent University Hospital"},{"author_name":"Steven Callens","author_inst":"Ghent University Hospital"},{"author_name":"Eva Van Braeckel","author_inst":"Ghent University Hospital"},{"author_name":"Thomas Malfait","author_inst":"Ghent University Hospital"},{"author_name":"Frank Vermassen","author_inst":"Ghent University Hospital"},{"author_name":"Bruno Verhasselt","author_inst":"Ghent University Hospital"},{"author_name":"Ashish Chikermane","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.05.20123463","rel_title":"UV-C irradiation is highly effective in inactivating and inhibiting SARS-CoV-2 replication","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123463","rel_abs":"The potential virucidal effects of UV-C irradiation on SARS-CoV-2 were experimentally evaluated for different illumination doses and virus concentrations (1000, 5, 0.05 MOI). Both virus inactivation and replication inhibition were investigated as a function of these parameters. At a virus density comparable to that observed in SARS-CoV-2 infection, an UV-C dose of just 3.7 mJ\/cm2 was sufficient to achieve a 3-log inactivation, and complete inhibition of all viral concentrations was observed with 16.9 mJ\/cm2. These results could explain the epidemiological trends of COVID-19 and are important for the development of novel sterilizing methods to contain SARS-CoV-2 infection.","rel_num_authors":14,"rel_authors":[{"author_name":"Andrea Bianco","author_inst":"Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Mara Biasin","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy"},{"author_name":"Giovanni Pareschi","author_inst":"Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Adalberto Cavalleri","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Claudia Cavatorta","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy."},{"author_name":"Claudio Fenizia","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy"},{"author_name":"Paola Galli","author_inst":"1 Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.06.20123901","rel_title":"CLINICAL PROPERTIES AND DIAGNOSTIC METHODS OF COVID-19 INFECTION IN PREGNANCIES: META-ANALYSIS","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.06.20123901","rel_abs":"We aimed to summarize reliable medical evidence by the meta-analysis of all published retrospective studies that examined data based on the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by clinical symptoms, molecular (RT-PCR) diagnosis and characteristic CT imaging features in pregnant women. MEDLINE PubMed, SCOPUS, ISI Web of Science, Clinical Key, and CINAHL databases were used to select the studies. Then, 384 articles were received, including the studies until 01\/MAY\/2020. As a result of the full-text evaluation, 12 retrospective articles covering all the data related were selected. A total of 181 pregnant cases with SARS-CoV-2 infections were included in the meta-analysis within the scope of these articles. According to the results, the incidence of fever was 38.1% (95% CI: 14.2-65%), and cough was 22% (95% CI: 10.8-35.2%) among all clinical features of pregnant cases with SARS-CoV-2 infection. So, fever and cough are the most common symptoms in pregnant cases with SARS-CoV-2 infection, and 91.8% (95% CI: 76.7-99.9%) of RT-PCR results are positive. Moreover, abnormal CT incidence is 97.9% (95% CI: 94.2-99.9%) positive. No case was death. However, as this virus spreads globally, it should not be overlooked that the incidence will increase in pregnant women and may be in the risky group. RT-PCR and CT can be used together in an accurate and safe diagnosis. In conclusion, these findings will provide important guidance for current studies regarding the clinical features and correct detection of SARS-CoV-2 infection in pregnant women, as well as whether it will create emergency tables that will require the use of a viral drug.","rel_num_authors":2,"rel_authors":[{"author_name":"Banu Uygun-Can","author_inst":"Marmara University"},{"author_name":"Bilge Acar-Bolat","author_inst":"Istanbul University, School of Business, Department of Quantitative Methods."},{"author_name":"Giovanni Pareschi","author_inst":"Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Adalberto Cavalleri","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Claudia Cavatorta","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy."},{"author_name":"Claudio Fenizia","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy"},{"author_name":"Paola Galli","author_inst":"1 Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.05.20123539","rel_title":"A shred of evidence that BCG vaccine may protect against COVID-19: Comparing cohorts in Spain and Italy","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123539","rel_abs":"Introduction: There is evidence that the BCG vaccine against tuberculosis also helps prevent other diseases- perhaps including COVD-19. Spain had a program for universal BCG vaccination until 1981. Objective: To see whether cohorts born when Spain had a program of universal BCG vaccination had lower rates of confirmed cases of COVID-19 and mortality (relative to similar cohorts in Italy). Methods: We compare COVID-19 mortality and confirmed cases for those born roughly a decade before and after 1981. We compare the outcomes to the same age cohorts in Italy, which never had universal BCG vaccination. Results: The Spanish cohort that received BCG had a relative risk of 0.962 of having a confirmed case of COVID-19. This risk is statistically significantly below unity (95% CI 0.952 to 0.972, P< 0.001). There is also suggestive evidence the BCG cohort in Spain had lower mortality (relative risk 0.929, CI 0.850 to 1.01, P = 0.11). The small sample size makes this test underpowered. Conclusion: These suggestive results provide a shred of evidence that BCG vaccinations help protect against COVID. I outline many limitations to this study and point how better data can help be more convincing.","rel_num_authors":1,"rel_authors":[{"author_name":"David I. Levine","author_inst":"University of California, Berkeley"},{"author_name":"Bilge Acar-Bolat","author_inst":"Istanbul University, School of Business, Department of Quantitative Methods."},{"author_name":"Giovanni Pareschi","author_inst":"Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Adalberto Cavalleri","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Claudia Cavatorta","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy."},{"author_name":"Claudio Fenizia","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy"},{"author_name":"Paola Galli","author_inst":"1 Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.06.20123919","rel_title":"Covid-19 Seroprevalence rate in healthy blood donors from a community under strict lockdown measures","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.06.20123919","rel_abs":"Background: Covid-19 seroprevalence rates and serological tests are important tools in understanding the epidemiology of the disease and help in the fight against it. Seroprevalence rates vary according to the population studied and the test employed and they range from 0.133 to 25.7%. The purpose of this study is to assess the seroprevalence rate in a population of healthy blood donors living under strict lockdown measures in Jordan which has in total 144 confirmed cases per million population. Methods: Left-over sera and plasma samples from 746 healthy blood donors were tested using a commercially available FDA approved kit having a sensitivity and specificity of 100% and 99.8% respectively. External positive controls were used for validation. Results: More than 80% of the donors were men 18-63 year old and residing in the capital city of Jordan, Amman. All tested specimens were negative yielding a zero seroprevalence rate in this healthy blood donor population. Conclusion: Strict lockdown measures effectively limit intracommunity spread of the infection, however at the cost of lack of any acquired community immunity. Additionally the use of highly specific test is recommended in low prevalence setting.","rel_num_authors":6,"rel_authors":[{"author_name":"Maher A Sughayer","author_inst":"king Hussein Cancer Center"},{"author_name":"Asem Mansour","author_inst":"King Hussein Cancer Center"},{"author_name":"Abeer Al Nuirat","author_inst":"King Hussein Cancer Center"},{"author_name":"Lina Souan","author_inst":"king Hussein Cancer Center"},{"author_name":"Mohammad Ghanem","author_inst":"king Hussein Cancer Center"},{"author_name":"Mahmoud Siag","author_inst":"King Hussein Cancer Center"},{"author_name":"Paola Galli","author_inst":"1 Italian National Institute for Astrophysics (INAF) Milano\/Merate, Italy."},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.06.20124016","rel_title":"Risk and protective factors of SARS-CoV-2 infection - Meta-regression of data from worldwide nations","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.06.20124016","rel_abs":"Although it has been reported that coexistent chronic diseases are strongly associated with COVID-19 severity, investigations of predictors for SARS-CoV-2 infection itself have been seldom performed. To screen potential risk and protective factors for SARS-CoV-2 infection, meta-regression of data from worldwide nations were herein conducted. We extracted total confirmed COVID-19 cases in worldwide 180 nations (May 31, 2020), nation total population, population ages 0-14\/65 and above, GDP\/GNI per capita, PPP, life expectancy at birth, medical-doctor and nursing\/midwifery-personnel density, hypertension\/obesity\/diabetes prevalence, annual PM2.5 concentrations, daily ultraviolet radiation, population using safely-managed drinking-water\/sanitation services and hand-washing facility with soap\/water, inbound tourism, and bachelor's or equivalent (ISCED 6). Restricted maximum-likelihood meta-regression in the random-effects model was performed using Comprehensive Meta-Analysis version 3. To adjust for other covariates, we conducted the hierarchical multivariate models. A slope (coefficient) of the meta-regression line for the COVID-19 prevalence was significantly negative for population ages 0-14 (-0.0636; P = .0021) and positive for obesity prevalence (0.0411; P = .0099) and annual PM2.5 concentrations in urban areas (0.0158; P = .0454), which would indicate that the COVID-19 prevalence decreases significantly as children increase and that the COVID-19 prevalence increases significantly as the obese and PM2.5 increase. In conclusion, children (negatively) and obesity\/PM2.5 (positively) may be independently associated with SARS-CoV-2 infection.","rel_num_authors":7,"rel_authors":[{"author_name":"Hisato Takagi","author_inst":"Shizuoka Medical Center"},{"author_name":"Toshiki Kuno","author_inst":"Mount Sinai Beth Israel Medical Center"},{"author_name":"Yujiro Yokoyama","author_inst":"Easton Hospital"},{"author_name":"Hiroki Ueyama","author_inst":"Mount Sinai Beth Israel Medical Center"},{"author_name":"Takuya Matsushiro","author_inst":"Shizuoka Medical Center"},{"author_name":"Yosuke Hari","author_inst":"Shizuoka Medical Center"},{"author_name":"Tomo Ando","author_inst":"New York Presbyterian Hospital\/Columbia University Medical Center"},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.06.05.20123752","rel_title":"Changes in non-linear and time-domain heart rate variability indices between critically ill COVID-19 and all-cause sepsis patients -a retrospective study","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123752","rel_abs":"Objective: To measure heart rate variability metrics in critically ill COVID-19 patients with comparison to all-cause critically ill sepsis patients. Design and patients: Retrospective analysis of COVID-19 patients admitted to an ICU for at least 24h at any of Emory Healthcare ICUs between March and April 2020. The comparison group was a cohort of all-cause sepsis patients prior to COVID-19 pandemic. Interventions: none. Measurements: Continuous waveforms were captured from the patient monitor. The EKG was then analyzed for each patient over a 300 second (s) observational window, that was shifted by 30s in each iteration from admission till discharge. A total of 23 HRV metrics were extracted in each iteration. We use the Kruskal-Wallis and Steel-Dwass tests (p < 0.05) for statistical analysis and interpretations of HRV multiple measures. Results: A total of 141 critically-ill COVID-19 patients met inclusion criteria, who were compared to 208 patients with all-cause sepsis. Demographic parameters were similar apart from a high proportion of African-Americans in the COVID-19 cohort. Three non-linear markers, including SD1:SD2, sample entropy, approximate entropy and four linear features mode of Beat-to-Beat interval (NN), Acceleration Capacity (AC), Deceleration Capacity (DC), and pNN50, were statistical significance between more than one binary combinations of the sub-groups (comparing survivors and non-survivors in both the COVID-19 and sepsis cohorts). The three nonlinear features and AC, DC, and NN (mode) were statistically significant across all four combinations. Temporal analysis of the main markers showed low variability across the 5 days of analysis, compared with sepsis patients. Conclusions: Heart rate variability is broadly implicated across patients infected with SARS-CoV-2, and admitted to the ICU for critical illness. Comparing these metrics to patients with all-cause sepsis suggests a unique set of expressions that differentiate this viral phenotype. This finding could be investigated further as a potential biomarker to predict poor outcome in this patient population, and could also be a starting point to measure potential autonomic dysfunction in COVID-19.","rel_num_authors":7,"rel_authors":[{"author_name":"Rishikesan Kamaleswaran","author_inst":"Emory University"},{"author_name":"Ofer Sadan","author_inst":"Emory University School of Medicine"},{"author_name":"Prem Kandiah","author_inst":"Emory University School of Medicine"},{"author_name":"Qiao Li","author_inst":"Emory University School of Medicine"},{"author_name":"James M Blum","author_inst":"Emory University School of Medicine"},{"author_name":"Craig M Coopersmith","author_inst":"Emory University School of Medicine"},{"author_name":"Timothy G Buchman","author_inst":"Emory University School of Medicine"},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"intensive care and critical care medicine"},{"rel_doi":"10.1101\/2020.06.05.20122903","rel_title":"Impact of Governmental interventions on epidemic progression and workplace activity during the COVID-19 outbreak","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20122903","rel_abs":"In the first quarter of 2020, the COVID-19 pandemic brought the world to a state of paralysis. During this period, humanity has seen by far the largest organized travel restrictions and unprecedented efforts and global coordination to contain the spread of the SARS-CoV-2 virus. Using large scale human mobility and fine grained epidemic incidence data, we develop a framework to understand and quantify the effectiveness of the interventions implemented by various countries to control epidemic growth. Our analysis reveals the importance of timing and implementation of strategic policy in controlling the epidemic. Through our analysis, we also unearth significant spatial diffusion of the epidemic before and during the lock-down measures in several countries, casting doubt on the effectiveness or on the implementation quality of the proposed Governmental policies.","rel_num_authors":2,"rel_authors":[{"author_name":"Sumit Kumar Ram","author_inst":"ETH Zurich"},{"author_name":"Didier Sornette","author_inst":"ETH Zurich"},{"author_name":"Prem Kandiah","author_inst":"Emory University School of Medicine"},{"author_name":"Qiao Li","author_inst":"Emory University School of Medicine"},{"author_name":"James M Blum","author_inst":"Emory University School of Medicine"},{"author_name":"Craig M Coopersmith","author_inst":"Emory University School of Medicine"},{"author_name":"Timothy G Buchman","author_inst":"Emory University School of Medicine"},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.06.05.20123695","rel_title":"Non-COVID-19 Deaths After Social Distancing in Norway","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123695","rel_abs":"Lay persons and policy makers have speculated on how the imposition of social distancing to reduce SARS CoV-2 (severe acute respiratory syndrome coronavirus 2) infection has affected non-COVID-19 (coronavirus disease of 2019) deaths. No rigorous estimation of the effect appears in the scholarly literature. We use time-series methods to compare non-COVID-19 deaths observed in Norway before and during the epidemic to those expected from non-COVID-19 deaths in Sweden as well as from the history of Norwegian mortality trends. We find that in the first 8 weeks after the divergence between Swedish and Norwegian policies (the only period for which dependable data can be had) approximately 414 fewer Norwegians died than expected.","rel_num_authors":4,"rel_authors":[{"author_name":"Ralph Catalano","author_inst":"University of California, Berkeley"},{"author_name":"Joan A Casey","author_inst":"Columbia University"},{"author_name":"Tim-Allen Bruckner","author_inst":"University of California, Irvine"},{"author_name":"Alison Gemmill","author_inst":"Johns Hopkins Bloomberg School of Public Health"},{"author_name":"James M Blum","author_inst":"Emory University School of Medicine"},{"author_name":"Craig M Coopersmith","author_inst":"Emory University School of Medicine"},{"author_name":"Timothy G Buchman","author_inst":"Emory University School of Medicine"},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.06.05.20123141","rel_title":"Heterogeneity is essential for contact tracing","rel_date":"2020-06-07","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.06.05.20123141","rel_abs":"Contact tracing is suggested as an effective strategy for controlling an epidemic without severely limiting personal mobility. Here, we explore how social structure affects contact tracing of COVID-19. Using smartphone proximity data, we simulate the spread of COVID-19 and find that heterogeneity in the social network and activity levels of individuals decreases the severity of an epidemic and improves the effectiveness of contact tracing. As a mitigation strategy, contact tracing depends strongly on social structure and can be remarkably effective, even if only frequent contacts are traced. In perspective, this highlights the necessity of incorporating social heterogeneity into models of mitigation strategies.","rel_num_authors":4,"rel_authors":[{"author_name":"Bjarke Frost Nielsen","author_inst":"Niels Bohr Institute, University of Copenhagen"},{"author_name":"Kim Sneppen","author_inst":"Niels Bohr Institute, University of Copenhagen"},{"author_name":"Lone Simonsen","author_inst":"Department of Science and Environment, Roskilde University"},{"author_name":"Joachim Mathiesen","author_inst":"Niels Bohr Institute, University of Copenhagen"},{"author_name":"James M Blum","author_inst":"Emory University School of Medicine"},{"author_name":"Craig M Coopersmith","author_inst":"Emory University School of Medicine"},{"author_name":"Timothy G Buchman","author_inst":"Emory University School of Medicine"},{"author_name":"Luigi Lessio","author_inst":"4 Italian National Institute for Astrophysics (INAF) Padova, Italy."},{"author_name":"Manuela Lualdi","author_inst":"Department of Imaging Diagnostic and Radioterapy, IRCCS Foundation, Istituto Nazionale dei Tumori, Milan, Italy"},{"author_name":"Edoardo Redaelli","author_inst":"1 Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Irma Saulle","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Daria Trabattoni","author_inst":"Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Milano, Italy."},{"author_name":"Alessio Zanutta","author_inst":"Italian National Institute for Astrophysics (INAF)  Milano\/Merate, Italy."},{"author_name":"Mario Clerici","author_inst":"Department of Pathophysiology and Transplantation, University of Milano and Don Gnocchi Foundation (Milano)"},{"author_name":"Steven Welch","author_inst":"University Hospitals Birmingham"},{"author_name":"Kavitha Masilamani","author_inst":"Birmingham Women's and Children's NHS Foundation Trust"},{"author_name":"Scott Hackett","author_inst":"University Hospitals Birmingham"},{"author_name":"Max Crispin","author_inst":"University of Southampton"},{"author_name":"Barnaby Scholefield","author_inst":"University of Birmingham"},{"author_name":"Adam F. Cunningham","author_inst":"University of Birmingham"},{"author_name":"Alex G. Richter","author_inst":"University of Birmingham"},{"author_name":"Vilayvong Loungnarath","author_inst":"CHU de Quebec"},{"author_name":"Gino Brochu","author_inst":"CIUSSS de la Mauricie-et-du-Centre-du-Quebec"},{"author_name":"Elie Haddad","author_inst":"CHU Ste-Justine"},{"author_name":"Hannah D Stacey","author_inst":"McMaster University"},{"author_name":"Matthew S Miller","author_inst":"McMaster University"},{"author_name":"Marc Desforges","author_inst":"CHU Ste-Justine"},{"author_name":"Pierre J Talbot","author_inst":"INRS"},{"author_name":"Graham T Gould Maule","author_inst":"University of Ottawa"},{"author_name":"Marceline Cote","author_inst":"University of Ottawa"},{"author_name":"Christian Therrien","author_inst":"LSPQ"},{"author_name":"Bouchra Serhir","author_inst":"LSPQ"},{"author_name":"Renee Bazin","author_inst":"Hema-Quebec"},{"author_name":"Michel Roger","author_inst":"LSPQ"},{"author_name":"Andres Finzi","author_inst":"Universite de Montreal"},{"author_name":"Peter Simmonds","author_inst":"University of Oxford"},{"author_name":"Teresa Lockett","author_inst":"NIHR Clinical Research Network Thames Valley & South Midlands"},{"author_name":"Robert Levin","author_inst":"Worthing Hospital"},{"author_name":"Shona C Moore","author_inst":"University of Liverpool"},{"author_name":"Mariolina Salio","author_inst":"University of Oxford"},{"author_name":"Giorgio Napolitani","author_inst":"University of Oxford"},{"author_name":"Yi-Ling Chen","author_inst":"University of Oxford"},{"author_name":"Susie Dunachie","author_inst":"University of Oxford"},{"author_name":"Piyada Supasa","author_inst":"University of Oxford"},{"author_name":"Chang Liu","author_inst":"University of Oxford"},{"author_name":"Cesar Lopez-Camacho","author_inst":"University of Oxford"},{"author_name":"Jose Slon-Campos","author_inst":"University of Oxford"},{"author_name":"Yuguang Zhao","author_inst":"University of Oxford"},{"author_name":"David I Stuart","author_inst":"University of Oxford"},{"author_name":"Guido Paeson","author_inst":"University of Oxford"},{"author_name":"Jonathan Grimes","author_inst":"University of Oxford"},{"author_name":"Fred Antson","author_inst":"University of York"},{"author_name":"Oliver W Bayfield","author_inst":"University of York"},{"author_name":"Dorothy EDP Hawkins","author_inst":"University of York"},{"author_name":"De-Sheng Ker","author_inst":"University of York"},{"author_name":"Azim Ansari","author_inst":"University of Oxford"},{"author_name":"Ellie Barnes","author_inst":"University of Oxford"},{"author_name":"John Frater","author_inst":"University of Oxford"},{"author_name":"Georgina Kerr","author_inst":"University of Oxford"},{"author_name":"Philip Goulder","author_inst":"University of Oxford"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"}]}



